Rep. Waxman issues letter regarding pediatric cough and cold medicines

WASHINGTON Rep. Henry Waxman, D-Calif., on Wednesday issued a letter addressing the Consumer Healthcare Products Association’s pending public comments on the labeling of pediatric cough and cold products before a Food and Drug Administration advisory committee meeting to be held later this month.

Waxman criticized CHPA’s advocacy of a ban on marketing products to children under the age of two even as several CHPA members have products targeting infants on the market.

In response, CHPA has issued a moratorium on advertising nonprescription medicines to children under the age of 2. “CHPA’s member companies are no longer advertising or promoting these medicines for infants and are individually working on their own transition plans to address the recommendations put forth in our background materials for the upcoming FDA advisory committee meeting,” stated Elizabeth Funderburk, CHPA director of communications and media relations, on Thursday.